Learn about the global anticoagulants market through The Business Research Company, which provides information on anticoagulants market size, anticoagulants market drivers and restraints, anticoagulants market players, the COVID-19 impact on the anticoagulants market, and more.

The global anticoagulants market size is expected to grow from $36.50 billion in 2021 to $40.34 billion in 2022 at a compound annual growth rate (CAGR) of 10.5%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The anticoagulant market is expected to reach $56.94 billion in 2026 at a CAGR of 9%.

The increasing cardiovascular diseases are a key factor driving the growth of the anticoagulants market over the coming years.

Request A Sample For The Global Anticoagulants Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5230&type=smp

The anticoagulants market consists of sales of anticoagulants by entities (organizations, sole traders, and partnerships) that manufacture anticoagulant drugs which keep blood vessels open and prevent the formation of blood clots. Anticoagulants are referred to as blood thinners, but they do not thin the blood, instead, they avoid or minimize clots or thrombi.

Global Anticoagulants Market Segments Include:
By Drug Class: Factor Xa Inhibitor, Heparin and LMWH, Vitamin K Antagonist, Others

By Route of Administration: Oral Anticoagulant, Injectable Anticoagulant

By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

By Application: Venous Thromboembolism, Atrial Fibrillation or Flutter, Coronary Artery Disease, Others

By End-User: Hospitals, Homecare, Specialty Centres, Others

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the anticoagulants market in 2021.

The ongoing clinical trials of anticoagulant treatments for COVID-19 are shaping the anticoagulants market. Major companies operating in the anticoagulants sector are concentrating on establishing clinical trials of anticoagulant medications to lower the risk of COVID-19 related blood clotting in adults.

TBRC’s anticoagulants market report covers:

Major Market Players: GlaxoSmithKline plc., Pfizer Inc., Sanofi, Mylan, Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo, Alexion Pharmaceuticals Inc., Otsuka and Leo Pharma.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The Anticoagulants Global Market Report 2022 –Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides anticoagulants market overviews, analyses and forecasts market size, share, anticoagulants market players, anticoagulants market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s anticoagulants market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Blood And Blood Components Global Market Report 2022

Pharmaceutical Drugs Global Market Report 2022

Cardiovascular Devices Global Market Report 2021

Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read More About Us At https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info

Found This Article Helpful? Share It On: